Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure

Circulation

Volumn 100, Issue 1, 1999, Pages 82-86

  DiBona, Gerald F ^a   Sawin, Linda L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adrenergic; Beta; Heart failure; Kidney; Metoprolol tartrate; Receptors

Indexed keywords

ISOPRENALINE; METOPROLOL; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; HEART INFARCTION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM LOAD; SODIUM URINE LEVEL;

EID: 0033529408     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.1.82     Document Type: Article

References (25)

1. The International Steering Committee on behalf of the MERIT-HF Study Group. Rationale, design and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF). Am J Cardiol. 1997;80(suppl 9B):54J-58J.
2. The Metoprolol in Dilated Cardiomyopathy (MDC) trial study group. Three year followup of patients randomized in the Metoprolol in Dilated Cardiomyopathy trial. Lancet. 1998;351:1180-1181.
3. Constant J. A review of why and how we may use beta-blockers in congestive heart failure. Chest. 1998;113:800-808.
4. Packer M. Beta-adrenergic blockade in chronic heart failure: principles, progress and practice. Prog Cardiovasc Dis. 1998;41(suppl 1):39-52.
5. Smits JF, Coleman TG, Smith TL, Kasbergen CM, van Essen H, Struyker-Boudier HA. Antihypertensive effect of propranolol in conscious spontaneously hypertensive rats: central hemodynamics, plasma volume and renal function during beta-blockade with propranolol. J Cardiovasc Pharmacol. 1982;4:903-914.
6. Struyker-Boudier HA, Smits JF. Antihypertensive action of beta-adrenoceptor blocking drugs: the role of intrarenal mechanisms. Am J Hypertens. 1989;2:237S-240S.
7. 1-Selektivität. Munchen, Germany: Verlag für angewandte Wissenschaften: 1984:11-32.
8. Zech P, Pozet N, Labeeuw M, Labille M, Hadj-Aissa A, Arkouche W, Poncet JF. Acute renal effects of beta-blockers. Am J Nephrol. 1986; 6(suppl 2):15-19.
9. Epstein M, Oster JR. Beta blockers and renal function: a reappraisal. J Clin Hypertens. 1985;1:85-99.
10. Bauer JH, Reams GP. Beta-adrenergic antagonists and the kidney. In: Bennett WM, McCarron DA, Brenner BM, Stein JH, eds. Contemporary Issues in Nephrology. Vol 19: Pharmacotherapy of Renal Disease and Hypertension. New York, NY: Churchill Livingstone; 1987:223-254.
11. Bauer JH, Reams GP. The effects of antihypertensive therapy on renal function. In: Kaplan NM, Brenner BM, Laragh JH, eds. Perspectives on Hypertension, Vol 3: New Therapeutic Strategies for Hypertension. New York, NY: Raven Press; 1989:253-287.
12. Bauer JH, Reams GP. Antihypertensive drugs. In: Brenner BM, ed. Brenner & Rector's The Kidney. New York, NY: WB Saunders; 1996: 2331-2381.
13. DiBona GF, Herman PJ, Sawin LL. Neural control of renal function in edema forming states. Am J Physiol. 1989;254:R1017-R1024.
14. DiBona GF, Jones SY, Brooks VL. Ang II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol 1995;269:R1189-R1196.
15. DiBona GF, Jones SY, Sawin LL. Angiotensin receptor antagonist improves cardiac reflex control of renal sodium handling in heart failure. Am J Physiol. 1998;274:H636-H641.
16. DiBona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol. 1991:260: R298-R305.
17. DiBona GF, Sawin LL. Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol. 1994;266:R27-R39.
18. Ervik M, Kylberg-Hansson K, Johansson L. Determination of metoprolol in plasma and urine using high-resolution gas chromatography and electron-capture detection. J Chromatogr Biomed Appl. 1986;381: 168-174.
19. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
20. Sugino G, Barg AP, O' Connor DT. Renal perfusion is preserved during cardioselective beta-blockade with metoprolol in hypertension. Am J Kidney Dis. 1984;3:357-361.
21. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197.
22. Kopp UC, DiBona GF. Neural regulation of renin secretion. Semin Nephrol. 1993;13:543-551.
23. Friggi A, Chevalier-Cholat A-M, Bodard H. Effects of a beta-adrenergic blocking drug, atenolol. on efferent renal nerve activity in rabbits. Experientia. 1977;33:1207-1208.
24. Friggi A, Chevalier-Cholat A-M, Torresani J. Reduction of efferent renal nerve activity by propranolol in rabbits. Acad Sci Comptes Rendus. 1977;284:1835-1837.
25. Gunning ME, Ingelfinger JR, King AJ, Brenner BM. Vasoactive peptides and the kidney. In: Brenner BM, ed. Brenner & Rector's The Kidney. New York, NY: WB Saunders; 1996:627-712.